Titre:
  • Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: A phase II study of the belgian group of digestive oncology
Auteur:Borbath, Ivan; Ceratti, Antonino; Verslype, Chris; Demols, Anne; Delaunoit, Thierry; Laurent, Stéphanie; Deleporte, Amélie; Vergauwe, Philippe; Van Maanen, Aline; Sempoux, Christine; Van Cutsem, Eric; Van Laethem, Jean-Luc
Informations sur la publication:Annals of oncology, 24, 11, page (2824-2829), mdt337
Statut de publication:Publié, 2013-11
Sujet CREF:Hématologie
Cancérologie
Mots-clés:Cetuximab
Chemotherapy
Cholangiocarcinoma
Gemcitabine
KRAS
MeSH keywords:Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects
Bile Duct Neoplasms -- drug therapy -- genetics -- pathology
Cholangiocarcinoma -- drug therapy -- genetics -- pathology
Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Proto-Oncogene Proteins -- genetics
ras Proteins -- genetics
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdt337
info:pii/mdt337
info:scp/84887105550
info:pmid/23975665